3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
12
Phase 3
3
Phase 1/2
3
Phase 4
2
Phase 1
2
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Leukemia
4
Leukemia, Myeloid, Chronic-Phase
2
Gastrointestinal Stromal Tumors
2
Blast Crisis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Piebaldism
1
Philadelphia Chromosome
1
Myeloproliferative Disorders
1
Interventions
nilotinib
2
flumatinib
2
Dasatinib
2
Thiotepa
1
Radiotherapy
1
Imatinib Mesylate
1
Filgrastim
1
Cyclophosphamide
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Leukemia, Myeloid, Chronic-Phase
×
nilotinib
×
Clear all
NCT01131325
2021-05-20
MACS1148
Novartis
Phase 4
Terminated
3 enrolled
4 charts
NCT03332511
2017-11-06
ENESTKorea
Seoul National University Hospital
Phase 4
Completed
110 enrolled